Yanjing Tang
Associate Chief Physician; MD; Deputy Director of the Innovation Diagnosis and Treatment Center
Innovation Diagnosis and Treatment Center, Ward 1
Shanghai Children's Medical Center International Department
The official SCMC page presents Tang Yanjing as a pediatric hematology-oncology specialist focused on relapsed and refractory leukemia, lymphoma, neuroblastoma, and CAR-T immunotherapy.
Biography
According to the official page, Tang Yanjing is an associate chief physician, MD, and deputy director of the Innovation Diagnosis and Treatment Center. The page highlights expertise in pediatric benign and malignant blood disease, CAR-T immunotherapy for relapsed or refractory leukemia and lymphoma, and publications in journals such as JCO, Leukemia, Journal of Translational Medicine, and Frontiers in Immunology.
Specialties
Practice Areas
- •Pediatric hematology-oncology
- •Cell therapy
- •Immunotherapy
Conditions Treated
Academic Titles
- •Deputy Director of the Innovation Diagnosis and Treatment Center
Education & Overseas Experience
The reviewed official page did not clearly list overseas training in the excerpt reviewed.
Signature Techniques
- ★CAR-T cell immunotherapy for relapsed or refractory hematologic malignancy
International Patient Fit
Strong fit for international families seeking advanced cell therapy and CAR-T options for relapsed or refractory pediatric blood cancers or selected solid tumors.
Achievements
- ★Deputy director of innovation diagnosis center
- ★Published in major hematology and oncology journals
Affiliated Hospital
Shanghai Children's Medical Center International DepartmentCredentials
- Associate Chief Physician
- MD